Literature DB >> 16188916

Micafungin in combination with voriconazole in Aspergillus species: a pharmacodynamic approach for detection of combined antifungal activity in vitro.

Russell E Lewis1, Dimitrios P Kontoyiannis.   

Abstract

OBJECTIVES: Preclinical and clinical evidence indicate that echinocandin-triazole combinations provide enhanced killing versus triazoles alone against some Aspergillus isolates, however, in vitro test results designed to detect this combined effect are difficult to interpret.
METHODS: We used a straightforward pharmacodynamic approach based on a microdilution format and a colorimetric analysis to harmonize growth end points.
RESULTS: We detected a fourfold decrease in the EC90 of voriconazole when tested in combination with micafungin (4 mg/L) against isolates of Aspergillus fumigatus and Aspergillus terreus, but not against an isolate of Aspergillus flavus. Echinocandin-enhanced voriconazole activity was confirmed in A. fumigatus and A. terreus but not A. flavus by fluorescent morbidity staining and fluorescence microscopic analysis of damaged hyphae.
CONCLUSIONS: A microdilution-based pharmacodynamic method for testing antifungal combinations provides a less ambiguous description of the combined effects of antifungals against moulds and could be useful in reference laboratories that routinely evaluate the activity of antifungal combinations in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16188916     DOI: 10.1093/jac/dki343

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  7 in total

Review 1.  Recent developments in the management of invasive fungal infections in patients with oncohematological diseases.

Authors:  Markus Ruhnke; Stefan Schwartz
Journal:  Ther Adv Hematol       Date:  2016-07-01

2.  Amphotericin B- and voriconazole-echinocandin combinations against Aspergillus spp.: Effect of serum on inhibitory and fungicidal interactions.

Authors:  Antigoni Elefanti; Johan W Mouton; Paul E Verweij; Athanassios Tsakris; Loukia Zerva; Joseph Meletiadis
Journal:  Antimicrob Agents Chemother       Date:  2013-07-15       Impact factor: 5.191

3.  Comparison Between Etest and Broth Microdilution Methods for Testing Itraconazole-Resistant Aspergillus fumigatus Susceptibility to Antifungal Combinations.

Authors:  Laura Bedin Denardi; Jéssica Tairine Keller; Maria Isabel de Azevedo; Vanessa Oliveira; Fernanda Baldissera Piasentin; Cecília Bittencourt Severo; Janio Morais Santurio; Sydney Hartz Alves
Journal:  Mycopathologia       Date:  2017-10-09       Impact factor: 2.574

4.  In vitro interaction of voriconazole and anidulafungin against triazole-resistant Aspergillus fumigatus.

Authors:  Seyedmojtaba Seyedmousavi; Joseph Meletiadis; Willem J G Melchers; Antonius J M M Rijs; Johan W Mouton; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2012-11-26       Impact factor: 5.191

5.  Comparative in vitro pharmacodynamics of caspofungin, micafungin, and anidulafungin against germinated and nongerminated Aspergillus conidia.

Authors:  Charalampos Antachopoulos; Joseph Meletiadis; Tin Sein; Emmanuel Roilides; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2007-10-15       Impact factor: 5.191

6.  Invasive aspergillosis in a renal transplant recipient successfully treated with interferon-gamma.

Authors:  C Estrada; A G Desai; L M Chirch; H Suh; R Seidman; F Darras; E P Nord
Journal:  Case Rep Transplant       Date:  2012-09-27

7.  Comparison of echinocandin antifungals.

Authors:  Gregory Eschenauer; Daryl D Depestel; Peggy L Carver
Journal:  Ther Clin Risk Manag       Date:  2007-03       Impact factor: 2.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.